LRRC4 inhibits glioma cell growth and invasion through a miR-185- dependent pathway

Current Cancer Drug Targets

Volumn 12, Issue 8, 2012, Pages 1032-1042

  Tang, Hailin ^a,b,c   Wang, Zeyou ^a   Liu, Xiaoping ^a   Liu, Qing ^b,d   Xu, Gang ^a   Li, Guiyuan ^a   Wu, Minghua ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The Center for Skull Base Surgery and Neurooncology   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CDC42; Glioma; Invasion; LRRC4; miRNA; RhoA

Indexed keywords

LEUCINE RICH REPEAT C4; MICRORNA; MICRORNA 185; PROTEIN CDC42; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE OVEREXPRESSION; GENETIC CODE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; BRAIN NEOPLASMS; CDC42 GTP-BINDING PROTEIN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLIN-DEPENDENT KINASE 6; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; NERVE TISSUE PROTEINS; RHOA GTP-BINDING PROTEIN; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84867758727     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800912803251180     Document Type: Article

References (24)

1. Zhang, Q.; Wang, J.; Fan, S.; Wang, L.; Cao, L.; Tang, K.; Peng, C.; Li, Z.; Li, W.; Gan, K.; Li, G. Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily. FEBS. Lett. 2005, 579, 3674-3682.
2. Li, A.; Walling, J.; Ahn, S.; Kotliarov, Y.; Su, Q.; Quezado, M.; Oberholtzer, J.C.; Park, J.; Zenklusen, J.C.; Fine, H.A. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer. Res. 2009, 69, 2091-2099.
3. Wang, J.R.; Qian, J.; Dong, L.; Li.; X.L.; Tan, C.; Li, G.Y. Identification of LRRC4, a Novel Member of Leucine-rich Repeat (LRR) Superfamily, and Its Expression Analysis in Brain Tumor. Prog. Biochem. Biophys. 2002, 29, 233-239.
4. Wu, M.; Huang, C.; Gan, K.; Huang, H.; Chen, Q.; Ouyang, J.; Tang, Y.; Li, X.; Yang, Y.; Zhou, H.; Li, G. LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathway. Mol. Biol. Cell. 2006, 17, 3534-3542.
5. Tang, H.; Liu, X.; Wang, Z.; She, X.; Zeng, X.; Deng, M.; Liao, Q.; Guo, X.; Wang, R.; Li, X.; Wu, M.; Li, G. Interaction of hsamiR-381 and glioma suppressor LRRC4 is involved in glioma growth. Brain. Res. 2011, 1390, 21-32.
6. Wu, M.; Huang, H.; Chen, Q.; Li, D.; Zheng, Z.; Xiong, W.; Zhou, Y.; Li, X.; Zhou, M.; Lu, J.; Li, G. Leucine-rich repeat C4 protein is involved in nervous tissue development and neurite outgrowth, and induction of glioma cell differentiation. Acta. Biochim. Biophys. Sin. 2007, 39, 731-738.
7. Wu, M.; Gan, K.; Huang, C.; Tang, Y.; Chen, Q.; Tang, K.; Li, X.; Shen, S.; Li, G. LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression. J. Neurooncol. 2006, 80, 133-142.
8. Zhang, Z.; Tang, H.; Wang, Z.; Zhang, B.; Deng, M.; Wu, M.; Li, G. Genome-wide DNA methylation analysis and miR-185 reduce GDM in glioma by Targeting DNA Methyltransferase 1. Mol. Cancer 2011, 10, 124.
9. Saniger, M. L.; Oya, R.; Macias, D.; Dominguez, J.N.; Aranega, A.; and Luque, F. c-Jun kinase mediates expression of VEGF induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA. J. Cell. Biochem. 2006, 98, 650-660.
10. Ellenbroek, S.I. and Collard, J.G. Rho GTPases: functions and association with cancer. Clin. Exp. Metastasis. 2007, 24, 657-672.
11. Sakurai-Yageta, M.; Recchi, C.; Le, Dez. G.; Sibarita, J.B.; Daviet, L.; Camonis, J.; D'Souza-Schorey, C.; Chavrier, P. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J. Cell. Biol. 2008, 181, 985-998.
12. Wu, M.; Chen, Q.; Li, D.; Li, X.; Li, X.; Huang, C.; Tang, Y.; Zhou, Y.; Wang, D.; Tang, K.; Li, G. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J. Cell. Biochem. 2008, 103, 245-255.
13. Wang, R.; Wang, Z.Y.; Yang, J.; Liu, X.P.; Wang, L.; Guo, X.F.; Wu, M.H.; Li, G.Y. LRRC4 inhibits the proliferation of human glioma cells by modulating the expression of STMN1 and microtubule polymerization. J. Cell. Biochem. 2011, 112, 3621-3629.
14. Jung, C.S.; Foerch, C.; Schanzer, A.; Heck, A.; Plate, K.H.; Seifert, V.; Steinmetz, H.; Raabe, A.; Sitzer, M. Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain. 2007, 130, 3336-3341.
15. Iorio, M.V.; Croce, C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 2012, 4, 143-159.
16. Lujambio, A.; Lowe, S.W. The microcosmos of cancer. Nature 2012, 482, 347-355.
17. Suzuki, H.I.; Yamagata, K.; Iwamoto, T.; Kat, S.; Miyazono, K. Modulation of microRNA processing by p53. Nature 2009, 460, 529-534.
18. Imam, J.S.; Buddavarapu, K.; Lee-Chang, J.S.; Ganapathy, S.; Camosy, C.; Chen, Y.; Rao, M.K. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 2010, 29, 4971-4979.
19. Liu, M.; Lang, N.; Chen, X.; Tang, Q.; Liu, S.; Huang, J.; Zheng, Y.; Bi, F. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer. Lett. 2011, 301, 151-160.
20. Ma, L. and Weinberg, R.A. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends. Genet. 2008, 24, 448-456.
21. Brock, M.; Trenkmann, M.; Gay, R.E.; Michel, B.A.; Gay, S.; Fischler, M.; Ulrich, S.; Speich, R.; Huber, L.C. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 2009, 104, 1184-1191.
22. Ma, L.; Young, J.; Prabhala, H.; Pan, E.; Mestdagh, P.; Muth, D.; Teruya-Feldstein, J.; Reinhardt, F.; Onder, T.T.; Valastyan, S. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell. Biol. 2010, 12, 247-256.
23. Schulte, J.H.; Horn, S.; Otto, T.; Samans, B.; Heukamp, L.C.; Eilers, U.C.; Krause, M.; Astrahantseff, K.; Klein-Hitpass, L.; Buettner, R. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int. J. Cancer 2008, 122, 699-704.
24. Yamakuchi, M.; Lotterman, C.D.; Bao, C.; Hruban, R.H.; Karim, B.; Mendell, J.T.; Huso, D.; Lowenstein, C.J. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc. Natl. Acad. Sci. USA 2009, 107, 6334-6339.